Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Amylin/Lilly Byetta Clears FDA As Adjunct Diabetes Therapy; Launch Is June

May 09 2005

• By The Pink Sheet

Related Content

Amylin Agrees To Symlin Marketing Restrictions In Gaining FDA Approval

Mar 21 2005

NME Outlook: Diabetes Drugs May Be Head Of The Class In 2005

Jan 01 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window